Market Place
Sourcing Support
Immunicom Receives NIH/NCI Grant for First US-Based Trial at Baylor
15 Jun 2022 //
TRIALSITENEWS
Immunicom Clinical Trial Data at ASCO 2022 Show Immunopheresis LW-02 Column
02 Jun 2022 //
BUSINESSWIRE
Immunicom Presents New Data at AACR of LW-02 Cartridge Immunopheresis Therapy
28 Apr 2022 //
BUSINESSWIRE
Immunicom Appoints Dr. Annette Marleau as Chief Technology Officer
17 Feb 2022 //
BUSINESSWIRE
Immunicom Announces Promising Preliminary Data from its Immunopheresis Study
07 Dec 2021 //
BUSINESSWIRE
Terumo, Immunicom Sign Agreement to Launch Breakthrough Cancer Immunotherapy
16 Nov 2021 //
PRNEWSWIRE
Immunicom Introduces Immunopheresis Therapy Platform against Cancer
21 Sep 2021 //
BUSINESSWIRE
Immunicom Presents Preliminary Data from Immunopheresis Studies at JCA-AACR 2021
14 Sep 2021 //
BUSINESSWIRE
Immunicom Hires Oncologist to Progress Launch of Non-Pharma Cancer Therapy
31 Aug 2021 //
BUSINESSWIRE
Immunicom Continues Successful Immunopheresis® Trial with Acibadem University
16 Aug 2021 //
BUSINESSWIRE
Immunicom Presentation Defines Breakthrough Subtractive Therapy’s Role
22 Jun 2021 //
BUSINESSWIRE
Immunicom Presents Clinical Trial Data with Novel Non-Pharma Immunotherapy
10 Jun 2021 //
BUSINESSWIRE
Immunicom Presents Promising Preliminary Data from Multiple Studies i
30 Apr 2021 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.